Articles tagged "Liver transplantation"

2020 American Transplant Congress
Percutaneous Choledochoscopy and Laser Biliary Stricturoplasty: A Case Series of Novel Management of Refractory Post-Liver Transplant Biliary Complications
W. E. Jackson¹, P. S. Trivedi², J. J. Pomposelli³, T. J. Pshak³
¹Division of Gastroenterology and Hepatology, University of Colorado, Aurora, CO, ²Division of Vascular and Interventional Radiology, University of Colorado, Aurora, CO, ³Division of Transplant Surgery, University of Colorado, Aurora, CO
*Purpose: Anastomotic biliary strictures are a well-recognized complication after living and deceased donor liver transplant (LDLT and DDLT). Management focuses on utilizing endoscopic retrograde cholangiography…
2020 American Transplant Congress
Risk Factors of Invasive Fungal Infections in Liver Transplantation: Systematic Review and Meta-Analysis
P. Phoompoung¹, S. Herrera², A. Perez Cortes Villalobos¹, F. Foroutan¹, A. Orchanian-Cheff¹, S. Husain¹
¹University Health Network, Toronto, ON, Canada, ²Hospital Universitario Ramón y Cajal, Universidad de Alcalá (IRYCIS), Madrid, Spain
*Purpose: Invasive fungal infection (IFI) remains one of the most common infectious complications after solid organ transplantation. Liver transplant recipients (LTRs) have a higher mortality…
2020 American Transplant Congress
Assessing Providers’ Accuracy in Predicting Early Readmission after Kidney and Liver Transplantation
K. Maroney, Z. Wang, R. Lynch, A. Adams, R. Patzer, J. Hogan
Emory University, Atlanta, GA
*Purpose: Predictive models capable of identifying patients at risk for readmission are in development. However, it is unknown how accurate clinicians are at predicting early…
2020 American Transplant Congress
Sex-Dependent Resistance to Ischemia-Reperfusion Injury in Mouse and Human Liver Transplantation
S. Kageyama, H. Kojima, K. Kadono, H. Hirao, K. J. Dery, S. Younan, T. Ito, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec-Weglinski
Surgery, Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Ischemia-reperfusion injury (IRI) is a major risk factor for early allograft dysfunction and rejection in orthotopic liver transplantation (OLT). The influence of sex on…
2020 American Transplant Congress
Changes in Risk Factors for Infections Post Liver Transplantation – A 16-Year Analysis
I. Bajjoka, S. Serra, J. Mourad, M. Callaghan, C. Crombez, S. Foley, M. Abouljoud
Transplant Institute, Henry Ford Hospital, Detroit, MI
*Purpose: Infections are common cause of morbidity and mortality post liver transplant (LT). Risk factors are related to donor and recipient factors, including cold ischemia…
2020 American Transplant Congress
Analysis of the Mechanism of Liver-Resident NK Cells Activity via the Aryl Hydrocarbon Receptor
K. Sato, M. Ohira, Y. Imaoka, H. Ohdan
Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan
*Purpose: Tumor recurrence is the main limitation of liver transplantation (LT) in patients with hepatocellular carcinoma (HCC). We previously reported an adoptive immunotherapy approach that…
2020 American Transplant Congress
Safety and Patency of Inferior Vena Cava Reconstruction with Artificial or Autologous Blood Vessels During Liver Autotransplantation: Five-Year Results from a Prospective Cohort Study of 73 Cases
T. Wang, X. Yang, W. Wang
Department of Liver Surgery & Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China
*Purpose: To compare the short-term and long-term effects of artificial blood vessels and autologous blood vessels to reconstruct the retrohepatic inferior vena cava (IVC) in…
2020 American Transplant Congress
Biomarkers AFP in Combination with AFP-l3 and DCP Predicts Tumor Progression in Treatment Native HCC Patients
K. Nunez, T. Sandow, P. Thevenot, A. Cohen
Ochsner Health System, New Orleans, LA
*Purpose: Hepatocellular carcinoma (HCC) treatment with locoregional therapy (LRT) is standard treatment to downstage within Milan Criteria. In this study, we retrospectively analyzed early-stage HCC…
2020 American Transplant Congress
In a Murine Model of Acetaminophen-Mediated Liver Injury, Tubastatin-a, An Hdac6-Specific Inhibitor, Improves Survival and Decreases Hepatocellular Injury
C. S. OBrien¹, P. T. Hernandez¹, S. J. Concors¹, L. N. Krumeich¹, Z. Wang¹, G. Ge¹, T. Bhatti², A. Kozikowski³, W. Hancock², M. H. Levine¹
¹Department of Surgery, University of Pennsylvania, Philadelphia, PA, ²Department of Pathology, Children's Hospital of Pennsylvania, Philadelphia, PA, ³Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, IL
*Purpose: Tylenol (APAP) toxicity, due to its narrow therapeutic window, is the leading cause of acute liver failure in the United States, resulting in approximately…
2020 American Transplant Congress
Cross-Validation of Performance-Based Frailty against Daily Step Count from Personal Activity Trackers – Refining Prehabilitation Tools in Liver Transplant Candidates
M. A. Hassan¹, M. A. Dunn¹, P. M. Bloomer¹, A. H. Gougol¹, M. Serper², D. R. Jorgensen¹, A. Duarte-Rojo¹
¹Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, ²Department of Medicine, University of Pennsylvania, Philadelphia, PA
*Purpose: The AST proposed a toolkit to identify frailty in liver transplant (LT) candidates, including the liver frailty index (LFI) and 6-min walk test (6MWT).…